Latest Insider Transactions at 89bio, Inc. (ETNB)
This section provides a real-time view of insider transactions for 89bio, Inc. (ETNB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 89bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 89bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 17
2023
|
Kathleen Laporte |
SELL
Open market or private sale
|
Direct |
12,500
-100.0%
|
$225,000
$18.8 P/Share
|
|
Jul 17
2023
|
Kathleen Laporte |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+50.0%
|
$25,000
$2.64 P/Share
|
|
Jun 30
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,882
-2.66%
|
$51,876
$18.95 P/Share
|
|
Jun 30
2023
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,334
+7.14%
|
-
|
|
Jun 30
2023
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
2,882
-1.66%
|
$51,876
$18.95 P/Share
|
|
Jun 30
2023
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
8,334
+4.59%
|
-
|
|
Jun 30
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,018
-3.4%
|
$36,324
$18.95 P/Share
|
|
Jun 30
2023
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,834
+8.94%
|
-
|
|
Jun 30
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,527
-5.13%
|
$297,486
$18.95 P/Share
|
|
Jun 30
2023
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,334
+9.38%
|
-
|
|
Jun 05
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.97%
|
$300,000
$20.0 P/Share
|
|
Jun 05
2023
|
Rohan Palekar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+4.73%
|
$15,000
$1.93 P/Share
|
|
Jun 01
2023
|
Edward Morrow Atkinson Iii |
SELL
Open market or private sale
|
Direct |
6,250
-100.0%
|
$106,250
$17.91 P/Share
|
|
Jun 01
2023
|
Edward Morrow Atkinson Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+50.0%
|
$12,500
$2.61 P/Share
|
|
May 09
2023
|
Quoc Le Nguyen |
SELL
Open market or private sale
|
Direct |
13,683
-7.66%
|
$246,294
$18.11 P/Share
|
|
May 09
2023
|
Quoc Le Nguyen |
BUY
Exercise of conversion of derivative security
|
Direct |
79,571
+18.51%
|
$238,713
$3.11 P/Share
|
|
Apr 04
2023
|
Ryan Martins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,721
-14.0%
|
$122,094
$14.95 P/Share
|
|
Mar 31
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,443
-5.11%
|
$231,645
$15.23 P/Share
|
|
Mar 31
2023
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,333
+9.93%
|
-
|
|
Mar 31
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,612
-3.7%
|
$69,180
$15.23 P/Share
|
|
Mar 31
2023
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,333
+9.65%
|
-
|
|
Mar 31
2023
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
4,179
-2.09%
|
$62,685
$15.23 P/Share
|
|
Mar 31
2023
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
12,083
+5.66%
|
-
|
|
Mar 31
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,882
-2.8%
|
$43,230
$15.23 P/Share
|
|
Mar 31
2023
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+7.48%
|
-
|
|
Mar 28
2023
|
Michael R Hayden |
BUY
Open market or private purchase
|
Indirect |
61,538
+50.0%
|
$984,608
$16.15 P/Share
|
|
Mar 24
2023
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,461,538
+18.18%
|
$39,384,608
$16.25 P/Share
|
|
Mar 23
2023
|
Ryan Martins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-8.54%
|
$80,000
$16.11 P/Share
|
|
Mar 23
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-5.28%
|
$240,000
$16.0 P/Share
|
|
Mar 01
2023
|
Edward Morrow Atkinson Iii |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$130,000
$13.6 P/Share
|
|
Mar 01
2023
|
Edward Morrow Atkinson Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$40,000
$4.44 P/Share
|
|
Feb 21
2023
|
Ryan Martins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,540
-4.16%
|
$33,020
$13.89 P/Share
|
|
Feb 17
2023
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
2,140
-2.29%
|
$27,820
$13.97 P/Share
|
|
Feb 17
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,750
-2.78%
|
$22,750
$13.97 P/Share
|
|
Feb 17
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,127
-2.2%
|
$27,651
$13.97 P/Share
|
|
Feb 17
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,279
-2.16%
|
$81,627
$13.97 P/Share
|
|
Feb 09
2023
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+20.53%
|
-
|
|
Feb 09
2023
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+23.66%
|
-
|
|
Feb 09
2023
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+32.3%
|
-
|
|
Feb 09
2023
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+24.33%
|
-
|
|
Feb 08
2023
|
Ryan Martins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,480
-4.31%
|
$20,720
$14.41 P/Share
|
|
Feb 05
2023
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
1,390
-2.15%
|
$18,070
$13.24 P/Share
|
|
Feb 05
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
592
-1.69%
|
$7,696
$13.24 P/Share
|
|
Feb 05
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,078
-1.86%
|
$53,014
$13.24 P/Share
|
|
Feb 05
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,360
-2.0%
|
$17,680
$13.24 P/Share
|
|
Feb 03
2023
|
Ryan Martins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,592
-4.4%
|
$43,104
$12.91 P/Share
|
|
Feb 03
2023
|
Ryan Martins Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.15%
|
$9,000
$3.11 P/Share
|
|
Feb 01
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-0.99%
|
$8,160
$12.05 P/Share
|
|
Feb 01
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
408
-1.12%
|
$4,896
$12.05 P/Share
|
|
Feb 01
2023
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
695
-1.06%
|
$8,340
$12.05 P/Share
|